PDCD1 and acute kidney injury: Another meta-analysis conducted by Wang et al. evaluated the incidence of ICI-related nephrotoxicity (increased sCr, nephritis, and renal failure) in 46 trials comprising 12,808 patients administered anti-PD-1 or anti-PD-L1 monotherapy (18).